(19)
(11) EP 2 073 863 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.03.2012 Bulletin 2012/12

(45) Mention of the grant of the patent:
19.10.2011 Bulletin 2011/42

(21) Application number: 07802801.6

(22) Date of filing: 22.08.2007
(51) International Patent Classification (IPC): 
A61M 1/36(2006.01)
(86) International application number:
PCT/EP2007/058729
(87) International publication number:
WO 2008/028807 (13.03.2008 Gazette 2008/11)

(54)

A FILTER FOR THE REMOVAL OF SUBSTANCES FROM BLOOD PRODUCTS

FILTER ZUR ENTFERNUNG VON SUBSTANZEN AUS BLUTPRÄPARATEN

FILTRE PERMETTANT DE RETIRER DES SUBSTANCES DE PRODUITS SANGUINS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 06.09.2006 EP 06425617

(43) Date of publication of application:
01.07.2009 Bulletin 2009/27

(73) Proprietor: Fresenius Hemocare Italia S.r.l.
I-41032 Cavezzo (Modena) (IT)

(72) Inventors:
  • BERTOLUCCI, Massimo
    I-55049 Viareggio (Lucca) (IT)
  • BONAGUIDI, Paolo
    I-56123 Pisa (IT)
  • BRUINI, Marco
    I-41030 Quarantoli (Modena) (IT)

(74) Representative: Richly, Erik 
Fresenius Kabi Deutschland GmbH Patent Department Else-Kröner-Strasse 1
61352 Bad Homburg
61352 Bad Homburg (DE)


(56) References cited: : 
WO-A-2005/113136
 US-A1- 2003 158 364
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).